
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Relief of tumor hypoxia unleashes the tumoricidal potential of neutrophils
Karim Mahiddine, Adam Blaisdell, Stephany Ma, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 1, pp. 389-403
Open Access | Times Cited: 101
Karim Mahiddine, Adam Blaisdell, Stephany Ma, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 1, pp. 389-403
Open Access | Times Cited: 101
Showing 1-25 of 101 citing articles:
Neutrophil diversity and plasticity in tumour progression and therapy
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 836
Sébastien Jaillon, Andrea Ponzetta, Diletta Di Mitri, et al.
Nature reviews. Cancer (2020) Vol. 20, Iss. 9, pp. 485-503
Closed Access | Times Cited: 836
Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 454
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 454
Neutrophils in cancer: heterogeneous and multifaceted
Catherine C. Hedrick, Ilaria Malanchi
Nature reviews. Immunology (2021) Vol. 22, Iss. 3, pp. 173-187
Closed Access | Times Cited: 448
Catherine C. Hedrick, Ilaria Malanchi
Nature reviews. Immunology (2021) Vol. 22, Iss. 3, pp. 173-187
Closed Access | Times Cited: 448
Neutrophils in cancer carcinogenesis and metastasis
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 331
Shu-Min Xiong, Liaoliao Dong, Lin Cheng
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 331
Therapeutic targeting of the hypoxic tumour microenvironment
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 313
Dean C. Singleton, Andrew Macann, William R. Wilson
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 12, pp. 751-772
Closed Access | Times Cited: 313
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 279
Hypoxia and the Tumor Microenvironment
Yue Li, Long Zhao, Xiaofeng Li
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 238
Yue Li, Long Zhao, Xiaofeng Li
Technology in Cancer Research & Treatment (2021) Vol. 20
Open Access | Times Cited: 238
Tumor-associated myeloid cells: diversity and therapeutic targeting
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 148
Alberto Mantovani, Federica Marchesi, Sébastien Jaillon, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 3, pp. 566-578
Open Access | Times Cited: 148
T cell immunotherapies engage neutrophils to eliminate tumor antigen escape variants
Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1432-1447.e17
Open Access | Times Cited: 146
Daniel Hirschhorn, Sadna Budhu, Lukas Kraehenbuehl, et al.
Cell (2023) Vol. 186, Iss. 7, pp. 1432-1447.e17
Open Access | Times Cited: 146
CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy
Yun Chang, Xuechao Cai, Ramizah Syahirah, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 105
Yun Chang, Xuechao Cai, Ramizah Syahirah, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 105
Hypoxia signaling in cancer: Implications for therapeutic interventions
Yan Zhuang, Kua Liu, Qinyu He, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 50
Yan Zhuang, Kua Liu, Qinyu He, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 50
Neutrophils in Cancer immunotherapy: friends or foes?
Xueqin Huang, Eugenie Nepovimová, Vojtěch Adam, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Xueqin Huang, Eugenie Nepovimová, Vojtěch Adam, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 31
Engineering and Targeting Neutrophils for Cancer Therapy
Jiahui Zhang, Jianmei Gu, Xu Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 24
Jiahui Zhang, Jianmei Gu, Xu Wang, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Open Access | Times Cited: 24
Pre-metastatic niche: formation, characteristics and therapeutic implication
Yuhang Wang, Jiachi Jia, Fuqi Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Yuhang Wang, Jiachi Jia, Fuqi Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 16
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC
Lena Horvath, Constanze Puschmann, Alexandra Scheiber, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 457-474
Open Access | Times Cited: 14
Lena Horvath, Constanze Puschmann, Alexandra Scheiber, et al.
Trends in cancer (2024) Vol. 10, Iss. 5, pp. 457-474
Open Access | Times Cited: 14
The heterogeneity of neutrophils in cancer and its implication for therapeutic targeting
Evgeniy Eruslanov, Yulia Nefedova, Dmitry I. Gabrilovich
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 17-28
Closed Access | Times Cited: 1
Evgeniy Eruslanov, Yulia Nefedova, Dmitry I. Gabrilovich
Nature Immunology (2025) Vol. 26, Iss. 1, pp. 17-28
Closed Access | Times Cited: 1
The balance between breast cancer and the immune system: Challenges for prognosis and clinical benefit from immunotherapies
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 117
Constantin N. Baxevanis, Sotirios P. Fortis, Sonia A. Perez
Seminars in Cancer Biology (2019) Vol. 72, pp. 76-89
Closed Access | Times Cited: 117
Current developments in nanotechnology for improved cancer treatment, focusing on tumor hypoxia
Cao Dai Phung, Tuan Hiep Tran, Le Minh Pham, et al.
Journal of Controlled Release (2020) Vol. 324, pp. 413-429
Closed Access | Times Cited: 99
Cao Dai Phung, Tuan Hiep Tran, Le Minh Pham, et al.
Journal of Controlled Release (2020) Vol. 324, pp. 413-429
Closed Access | Times Cited: 99
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer
Antonietta R. Farina, Lucia Cappabianca, M. Di Katie Sebastiano, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 96
Antonietta R. Farina, Lucia Cappabianca, M. Di Katie Sebastiano, et al.
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 96
Neutrophil dynamics in the tumor microenvironment
Amanda J. McFarlane, Frédéric Fercoq, Seth B. Coffelt, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 85
Amanda J. McFarlane, Frédéric Fercoq, Seth B. Coffelt, et al.
Journal of Clinical Investigation (2021) Vol. 131, Iss. 6
Open Access | Times Cited: 85
The Neutrophil: Constant Defender and First Responder
Noah Fine, Nikola Tasevski, Christopher A. McCulloch, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 82
Noah Fine, Nikola Tasevski, Christopher A. McCulloch, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 82
Tumour Hypoxia-Mediated Immunosuppression: Mechanisms and Therapeutic Approaches to Improve Cancer Immunotherapy
Zhe Fu, Alexandra M. Mowday, Jeff B. Smaill, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 79
Zhe Fu, Alexandra M. Mowday, Jeff B. Smaill, et al.
Cells (2021) Vol. 10, Iss. 5, pp. 1006-1006
Open Access | Times Cited: 79
Two-Faced Roles of Tumor-Associated Neutrophils in Cancer Development and Progression
Naofumi Mukaida, Soichiro Sasaki, Tomohisa Baba
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3457-3457
Open Access | Times Cited: 71
Naofumi Mukaida, Soichiro Sasaki, Tomohisa Baba
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 10, pp. 3457-3457
Open Access | Times Cited: 71
Roles of Neutrophils in Glioma and Brain Metastases
Ya-Jui Lin, Kuo‐Chen Wei, Pin‐Yuan Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Ya-Jui Lin, Kuo‐Chen Wei, Pin‐Yuan Chen, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 67
Secreted protease PRSS35 suppresses hepatocellular carcinoma by disabling CXCL2-mediated neutrophil extracellular traps
Ting Wang, Yingli Zhou, Zilong Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26
Ting Wang, Yingli Zhou, Zilong Zhou, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 26